Table 2. Course of lung function in the study subjects.a .
| Variable | Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | After 14m | Baseline | After 60m | Baseline | After 56m | Baseline | After 30m | Baseline | After 24m | |
| FVC, L | 4.17 (79%) | 3.74 (67%) | 2.85 (63%) | 2.88 (59%) | 3.47 (63%) | 4.12 (76%) | 2.22 (49%) | 1.76 (39%) | 2.81 (83%) | 2.33 (61%) |
| FEV1, L | 3.54 (83%) | 3.20 (73%) | 2.45 (65%) | 2.38 (60%) | 2.73 (60%) | 3.08 (68%) | 2.09 (56%) | 1.70 (46%) | 2.32 (86%) | 1.94 (69%) |
| FEV1/FVC | 0.85 | 0.86 | 0.86 | 0.83 | 0.81 | 0.75 | 0.94 | 0.94 | 0.82 | 0.83 |
| TLC, L | NA | 5.57 (75%) | 4.31 (68%) | 5.11 (83%) | 5.19 (66%) | 5.89 (75%) | 3.80 (56%) | NA | 4.07 (65%) | 4.06 (65%) |
| RV, L | NA | 1.84 (91%) | 1.56 (96%) | 2.09 (142%) | 1.47 (79%) | 1.83 (98%) | 1.54 (77%) | NA | 1.29 (54%) | 1.67 (76%) |
| DLCO, mL/min/mmHg | NA | NA | 22.76 (72%) | 28.89 (106%) | 32.44 (93%) | 43.25 (107%) | 6.15 (20%) | NA | 19.39 (67%) | 11.29 (39%) |
m: months; and NA: not assessed. aPercent predicted values calculated for the Brazilian population according to Neder et al. 32